ArmonAir digihaler 55 mcg/INHAL Dry Powder Inhaler, 60 Actuations
RxNorm 2395840
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2395840 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ArmonAir digihaler 55 mcg/INHAL Dry Powder Inhaler, 60 Actuations.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
ArmonAir digihaler 55 mcg/INHAL Dry Powder Inhaler, 60 Actuations
(Atom ID: 12435435)
SYPrescribable
Synonym (SY):
ArmonAir digihaler 55 mcg/INHAL Dry Powder Inhaler, 60 Actuations
(Atom ID: 12435437)
SYPrescribable
Synonym (SY):
Sensor 60 ACTUAT Armonair 0.055 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 12435436)
SBDPrescribable
Semantic Branded Drug (SBD):
Sensor 60 ACTUAT fluticasone propionate 0.055 mg/ACTUAT Dry Powder Inhaler [Armonair]
(Atom ID: 12435434)
Patient Education
Fluticasone Oral Inhalation
Fluticasone oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children. It is in a class of medications called corticosteroids. Fluticasone works by decreasing swelling and irritation in the airways to allow for easier breathing.
[Learn More]
* Please review the disclaimer below.